Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
AJANTA PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AJANTA PHARMA Mar-23 |
TEVA PHARMA Dec-13 |
AJANTA PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,426 | 3,486 | - | |
Low | Rs | 1,062 | 3,028 | - | |
Sales per share (Unadj.) | Rs | 297.2 | 2,000.5 | - | |
Earnings per share (Unadj.) | Rs | 46.7 | 125.0 | - | |
Cash flow per share (Unadj.) | Rs | 57.1 | 286.7 | - | |
Dividends per share (Unadj.) | Rs | 7.00 | 109.40 | - | |
Avg Dividend yield | % | 0.6 | 3.4 | 16.8% | |
Book value per share (Unadj.) | Rs | 269.1 | 2,222.2 | - | |
Shares outstanding (eoy) | m | 125.91 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.2 | 1.6 | 257.1% | |
Avg P/E ratio | x | 26.6 | 26.1 | 102.2% | |
P/CF ratio (eoy) | x | 21.8 | 11.4 | 191.8% | |
Price / Book Value ratio | x | 4.6 | 1.5 | 315.5% | |
Dividend payout | % | 15.0 | 87.5 | 17.1% | |
Avg Mkt Cap | Rs m | 156,638 | 2,761,843 | 5.7% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 7,851 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,744.4 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,357.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 37,426 | 1,696,422 | 2.2% | |
Other income | Rs m | 986 | 0 | - | |
Total revenues | Rs m | 38,413 | 1,696,422 | 2.3% | |
Gross profit | Rs m | 7,833 | 464,566 | 1.7% | |
Depreciation | Rs m | 1,308 | 137,123 | 1.0% | |
Interest | Rs m | 58 | 33,320 | 0.2% | |
Profit before tax | Rs m | 7,453 | 294,122 | 2.5% | |
Minority Interest | Rs m | 0 | 1,336 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -193,075 | -0.0% | |
Tax | Rs m | 1,573 | -3,591 | -43.8% | |
Profit after tax | Rs m | 5,880 | 105,974 | 5.5% | |
Gross profit margin | % | 20.9 | 27.4 | 76.4% | |
Effective tax rate | % | 21.1 | -1.2 | -1,728.5% | |
Net profit margin | % | 15.7 | 6.2 | 251.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 28,252 | 1,145,757 | 2.5% | |
Current liabilities | Rs m | 11,393 | 999,197 | 1.1% | |
Net working cap to sales | % | 45.0 | 8.6 | 521.4% | |
Current ratio | x | 2.5 | 1.1 | 216.3% | |
Inventory Days | Days | 66 | 91 | 72.5% | |
Debtors Days | Days | 10 | 96 | 10.7% | |
Net fixed assets | Rs m | 18,707 | 554,089 | 3.4% | |
Share capital | Rs m | 253 | 4,176 | 6.1% | |
Net worth | Rs m | 33,877 | 1,884,403 | 1.8% | |
Long term debt | Rs m | 13 | 867,418 | 0.0% | |
Total assets | Rs m | 47,047 | 3,876,868 | 1.2% | |
Interest coverage | x | 128.6 | 9.8 | 1,308.7% | |
Debt to equity ratio | x | 0 | 0.5 | 0.1% | |
Sales to assets ratio | x | 0.8 | 0.4 | 181.8% | |
Return on assets | % | 12.6 | 3.6 | 351.3% | |
Return on equity | % | 17.4 | 5.6 | 308.6% | |
Return on capital | % | 22.2 | 4.9 | 449.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 7,918 | 270,322 | 2.9% | |
From Investments | Rs m | -5,596 | -95,786 | 5.8% | |
From Financial Activity | Rs m | -1,079 | -324,269 | 0.3% | |
Net Cashflow | Rs m | 1,243 | -149,733 | -0.8% |
Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare AJANTA PHARMA With: SANDU PHARMA VEERHEALTH CARE JFL LIFE SCIENCES LTD. RAJNISH WELLNESS UNICK FIX-A-FORM AND PRINTERS
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.